NCT03896243 is a clinical trial of Uterine artery ligation (UAL) in Uterine Artery Ligation, sponsored by Kanuni Sultan Suleyman Training and Research Hospital.

Who is sponsoring NCT03896243?

NCT03896243 is sponsored by Kanuni Sultan Suleyman Training and Research Hospital.

What drugs are being tested in NCT03896243?

Interventions in NCT03896243: Uterine artery ligation (UAL).

What condition does NCT03896243 study?

NCT03896243 studies Uterine Artery Ligation, Ovarian Reserve.

Is NCT03896243 still recruiting?

NCT03896243 is currently completed. Last updated 29 March 2019.

Last reviewed 2019-03-29 · How we verify

NCT03896243

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Serum Antimullerian Hormone Levels in Patients Who Underwent Uterine Artery Ligation

Completed Last updated 29 March 2019

What this trial tests

trial testing Uterine artery ligation (UAL) in Uterine Artery Ligation in 102 participants. Completed in 1 February 2019.

Timeline

1 January 2018

Primary endpoint
1 January 2019

1 February 2019

Quick facts

Lead sponsor	Kanuni Sultan Suleyman Training and Research Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	102
Start date	1 January 2018
Primary completion	1 January 2019
Estimated completion	1 February 2019
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Uterine artery ligation (UAL)

Conditions studied

Uterine Artery Ligation — all drugs for Uterine Artery Ligation →
Ovarian Reserve — all drugs for Ovarian Reserve →

Sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Who can join

Adults 18 to 35, female only, with Uterine Artery Ligation or Ovarian Reserve. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators would like to see the amh values after uterine artery ligation

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Kanuni Sultan Suleyman Training and Research Hospital trials

Trials by the same sponsor.

NCT07519551 — Serum Myostatin and Irisin Levels in Postmenopausal Women: Association With Bone Mineral Density and Muscle Strength · not yet recruiting
NCT07480330 — Serum Neurofilament Light Chain Levels and Neuropathy Severity in Diabetic Polyneuropathy · not yet recruiting
NCT07425405 — Daily Screen Exposure and Preoperative Anxiety in Children Aged 2-5 Years · recruiting
NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
NCT07261436 — Performance Comparison of Large Language Models in TAP Block Ultrasound Interpretation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03896243 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kanuni Sultan Suleyman Training and Research Hospital
Last refreshed: 29 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03896243.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing